The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡
Open accessAbstract
Beta-blockers may have a negative impact on survival in patients with cirrhosis and refractory ascites. The aim of this study was to evaluate the effect of the administration of beta-blockers on long-term survival in patients with cirrhosis and refractory ascites. We performed a single-center, observational, case-only, prospective study of patients with cirrhosis and refractory ascites who did or did not receive beta-blockers for the prevention of gastrointestinal bleeding; 151 patients were included. The mean Model for End-Stage Liver Disease score was 18.8 ± 4.1. All patients regularly underwent large-volume paracentesis and intravenous albumin administration. Seventy-seven patients (51%) were treated with propranolol (113 ± 46 mg/day). The median follow-up for the whole group was 8 months. The median survival time was 10 months [95% confidence interval (CI) = 8-12 months]. The probability of survival at 1 year was 41% (95% CI = 33%-49%). The clinical characteristics and laboratory values at enrolment were not significantly different between patients who were receiving propranolol and those who were not. The median survival time was 20.0 months (95% CI = 4.8-35.2 months) in patients not treated with propranolol and 5.0 months (95% CI = 3.5-6.5 months) in those treated with propranolol ( P = 0.0001). The 1-year probability of survival was significantly lower in patients who received propranolol [19% (95% CI = 9%-29%)] versus those who did not [64% (95% CI = 52%-76%), P < 0.0001]. The independent variables of mortality were Child-Pugh class C, hyponatremia and renal failure as causes of refractory ascites, and beta-blocker therapy. Conclusion: The use of beta-blockers is associated with poor survival in patients with refractory ascites. These results suggest that beta-blockers should be contraindicated in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., & Carey, W. (2007) · Hepatology · doi:10.1002/hep.21907 · Cited by 1,722
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
Arroyo, V, Ginès, P., Gerbes, A. L., Dudley, F. J., Gentilini, P., Laffi, G., Reynolds, T. B., Ring-Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,703
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
Kim, W. R., Biggins, S. W., Kremers, W. K., Wiesner, R. H., Kamath, P. S., Benson, J. T., Edwards, E., & Therneau, T. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801209 · Cited by 1,486
Moore, K. P., Wong, F., Gines, P., Bernardi, M., Ochs, A., Salerno, F., Angeli, P., Porayko, M., Moreau, R., Garcia-Tsao, G., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50315 · Cited by 967
Self-citationEvidence-Based Incorporation of Serum Sodium Concentration Into MELD
Biggins, S. W., Kim, W. R., Terrault, N. A., Saab, S., Balan, V., Schiano, T., Benson, J., Therneau, T., Kremers, W., Wiesner, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.010 · Cited by 790
Management of Cirrhosis and Ascites
Ginès, P., Cárdenas, A., Arroyo, V., & Rodés, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035021 · Cited by 773
Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD
Durand, F., & Valla, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.015 · Cited by 656
Self-citationGines, A., Fernandez-Esparrach, G., Monescillo, A., Vila, C., Domenech, E., Abecasis, R., Angeli, P., Ruiz-Del-Arbol, L., Planas, R., Sola, R., et al. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70068-9 · Cited by 604
Circulatory function and hepatorenal syndrome in cirrhosis†
Ruiz‐del‐Arbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., María Milicua, J., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 592
Franchis, R. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80320-7 · Cited by 587
Cited by
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.024 · Cited by 2,905
Self-citationGarcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., & Kim, W. R. (2021) · Hepatology · doi:10.1002/hep.31884 · Cited by 846
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
Tripathi, D., Stanley, A. J., Hayes, P. C., Patch, D., Millson, C., Mehrzad, H., Austin, A., Ferguson, J. W., Olliff, S. P., Hudson, M., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309262 · Cited by 795
Runyon, B. A. (2013) · Hepatology · doi:10.1002/hep.26359 · Cited by 778
Guidelines on the management of ascites in cirrhosis
Aithal, G. P., Palaniyappan, N., China, L., Härmälä, S., Macken, L., Ryan, J. M., Wilkes, E. A., Moore, K., Leithead, J. A., Hayes, P. C., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321790 · Cited by 680
Interactions of the heart and the liver
Møller, S., & Bernardi, M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht246 · Cited by 490
Kaplan, D. E., Ripoll, C., Thiele, M., Fortune, B. E., Simonetto, D. A., Garcia-Tsao, G., & Bosch, J. (2024) · Hepatology · doi:10.1097/hep.0000000000000647 · Cited by 486
Bureau, C., Thabut, D., Oberti, F., Dharancy, S., Carbonell, N., Bouvier, A., Mathurin, P., Otal, P., Cabarrou, P., Péron, J. M., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.016 · Cited by 452
Immune Dysfunction and Infections in Patients With Cirrhosis
Bonnel, A. R., Bunchorntavakul, C., & Reddy, K. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.031 · Cited by 396
Spontaneous bacterial peritonitis: recent guidelines and beyond
Wiest, R., Krag, A., & Gerbes, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300779 · Cited by 386
Mandorfer, M., Bota, S., Schwabl, P., Bucsics, T., Pfisterer, N., Kruzik, M., Hagmann, M., Blacky, A., Ferlitsch, A., Sieghart, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.005 · Cited by 378
EASL Clinical Practice Guidelines on acute-on-chronic liver failure
Moreau, R., Tonon, M., Krag, A., Angeli, P., Berenguer, M., Berzigotti, A., Fernandez, J., Francoz, C., Gustot, T., Jalan, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.021 · Cited by 375
Self-citationTreatment of Patients with Cirrhosis
Ge, P. S., & Runyon, B. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1504367 · Cited by 348
Reiberger, T., Ulbrich, G., Ferlitsch, A., Payer, B. A., Schwabl, P., Pinter, M., Heinisch, B. B., Trauner, M., Kramer, L., Peck-Radosavljevic, M., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304038 · Cited by 342
Reiberger, T., Ferlitsch, A., Payer, B. A., Mandorfer, M., Heinisch, B. B., Hayden, H., Lammert, F., Trauner, M., Peck-Radosavljevic, M., & Vogelsang, H. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.011 · Cited by 329
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
Wiese, S., Hove, J. D., Bendtsen, F., & Møller, S. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.210 · Cited by 267
Verbeke, L., Farre, R., Trebicka, J., Komuta, M., Roskams, T., Klein, S., Elst, I. V., Windmolders, P., Vanuytsel, T., Nevens, F., et al. (2014) · Hepatology · doi:10.1002/hep.26939 · Cited by 258
Sauerbruch, T., Mengel, M., Dollinger, M., Zipprich, A., Rössle, M., Panther, E., Wiest, R., Caca, K., Hoffmeister, A., Lutz, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.011 · Cited by 261
Mookerjee, R. P., Pavesi, M., Thomsen, K. L., Mehta, G., Macnaughtan, J., Bendtsen, F., Coenraad, M., Sperl, J., Gines, P., Moreau, R., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.018 · Cited by 248
Self-citationSchwabl, P., Hambruch, E., Seeland, B. A., Hayden, H., Wagner, M., Garnys, L., Strobel, B., Schubert, T.-L., Riedl, F., Mitteregger, D., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.005 · Cited by 178
Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
Madsen, B. S., Havelund, T., & Krag, A. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0044-1 · Cited by 38
Paternostro, R., Becker, J., Hofer, B. S., Panagl, V., Schiffke, H., Simbrunner, B., Semmler, G., Schwabl, P., Scheiner, B., Bucsics, T., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.09.009 · Cited by 17
Sharma, S., Stine, J. G., Verbeek, T., & Bezinover, D. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.07.020 · Cited by 5
Metadata
- Authors
- Sersté, T., Melot, C., Francoz, C., Durand, F., Rautou, P.-E., Valla, D., Moreau, R., & Lebrec, D.
- Venue
- Hepatology
- Published
- 2010-09
- Volume
- 52
- Issue
- 3
- Pages
- 1017-1022
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2111820868
- Cited by
- 530
- References
- 23
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.